Amparo García-Burillo

Amparo García-Burillo

Auto-generated profile, based on publicly available information

Amparo García-Burillo

Nuclear Medicine Department, Hospital Universitario Vall d‘Hebron , Barcelona, 08035

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 1997 in JACC
Verified
Journal Article
Closed access
JCJaume Candell-Riera
Jaume Candell-Riera
CSCésar Santana-Boado
César Santana-Boado
JCJoan Castell-Conesa
Joan Castell-Conesa
SASantiago Aguadé-Bruix
Santiago Aguadé-Bruix
MOMontserrat Olona
Montserrat Olona
JSJordi Soler-Soler
Jordi Soler-Soler

1 May 1998
Verified
Journal Article
Closed access
CSC Santana-Boado
C Santana-Boado
JCJ Candell-Riera
J Candell-Riera
JCJ Castell-Conesa
J Castell-Conesa
SAS Aguadé-Bruix
S Aguadé-Bruix
AGA García-Burillo
A García-Burillo
JSJ Soler-Soler
J Soler-Soler

2 August 2013 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
AGAmparo Garcia-Burillo
Amparo Garcia-Burillo
IBIsabel Roca Bielsa
Isabel Roca Bielsa
OGOscar Gonzalez
Oscar Gonzalez
CZCarles Zafon
Carles Zafon
MSMonica Sabate
Monica Sabate
JCJoan Castell-Conesa
Joan Castell-Conesa

1 January 1997 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
JCJoan Castell Conesa
Joan Castell Conesa
CBCésar Santana Boado
César Santana Boado
SBSantiago Aguadé Bruix
Santiago Aguadé Bruix
TCTeresa Canela
Teresa Canela
ABAmparo García Burillo
Amparo García Burillo
JSJordi Soler Soler
Jordi Soler Soler

23 December 2014 in Journal of Investigative Surgery
Verified
Journal Article
Closed access
OGOscar González
Oscar González
CICarmela Iglesias
Carmela Iglesias
CZCarles Zafon
Carles Zafon
JCJosep Castellvi
Josep Castellvi
AGAmparo García-Burillo
Amparo García-Burillo
JBJosé M Balibrea
José M Balibrea
Purpouse: One Step Nucleic Acid Amplification (OSNA) has been previously proposed for the diagnosis of lymph node metastases (LNMs) from several malignant conditions by quantifying the number of copies of cytokeratin 19 mRNA. Our aim was to evaluate the results obtained by OSNA in the lymph nodes of patients with papillary thyroid carcinoma (PTC) by comparing our results with the findings observed using standard pathological examination. Fifty human lymph nodes (from five patients with diagnosed PTC) were studied. Each node was divided into two: one half was used for molecular study ("OSNA-node"), and the other half was used for conventional staining with hematoxylin and eosin ("HE-non-OSNA node"). Three cytological imprints using Papanicolaou and May-Grunwald-Giemsa strains were obtained from both node halves. The results from each technique were compared, and ROC analysis was performed. The OSNA study showed 22 positive samples for LNM (44%), which demonstrate a high concordance rate with the results observed using conventional pathological examination (cytology of "OSNA-node" and HE of "Non-OSNA node") with specificity and sensitivity values greater than 86% and 89%, respectively. However, both comparisons differed in the number of copies of mRNA as the best cut-off (260 copies in the first case and 93 in the second case). The OSNA results for the detection of LNM in patients with PTC are comparable with those observed using conventional techniques. However, its quantitative nature could be useful to more accurately detect lymph node involvement.

1 September 2001 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
JCJ. Candell-Riera
J. Candell-Riera
GOG. Oller-Martínez
G. Oller-Martínez
JRJ. Rosselló
J. Rosselló
OPO. Pereztol-Valdés
O. Pereztol-Valdés
JCJ. Castell-Conesa
J. Castell-Conesa
JSJ. Soler-Soler
J. Soler-Soler
Background The objective of this study was to determine the prevalence of anterior and septal defects in patients with left bundle branch block (LBBB), and to assess the diagnostic accuracy of myocardial single photon emission computed tomography (SPECT) with technetium compounds in patients with and without LBBB using standard provocative manoeuvres. Methods Five hundred and nine consecutive patients (456 without LBBB and 53 with LBBB) without previous infarction who had a coronary angiography performed within <3 months of the scintigraphic study were retrospectively evaluated. The same stress procedures were followed in all patients. (1) Only exercise when it was sufficient; and (2) exercise+simultaneous administration of dypiridamole if exercise was insufficient. Only reversible defects were considered positive and ≥50% of coronary stenosis was considered significant. Results Prevalence of reversible anterior and septal defects was low (33% and 12%, respectively) in patients with LBBB. Although lower values of global sensitivity (81%) and specificity (73%) were obtained in these patients, there were no significant differences with respect to the patients without LBBB (89% and 86%, respectively). Specificity values for the diagnosis of stenosis of left anterior descending (78%), left circumflex (96%) and right coronary artery (74%) in patients with LBBB were lower, but without significant statistical differences with respect patients without LBBB (90%, 96% and 82%, respectively). Conclusions Myocardial SPECT with technetium compounds, using standard provocation manoeuvres, can be used in patients with LBBB with only a mild decrease in diagnostic accuracy as compared to patients without LBBB.